Skip to main content
NIH funding notice RFA-DA-22-003

Elucidating the Effects of ART on Neuronal Function in the Context of SUD and HIV (R01 - Clinical Trials Not Allowed)

Closed on February 2, 2022.

Posted
June 23, 2021
Close date
February 2, 2022
Activity codes
Not stated on the notice page
Institutes taking part
Not stated on the notice page

Read the notice on Grants.gov · NIH Guide page

The notices it replaced

Its page was not saved, so the notices it replaced are not known.

Who won it before

3 competing awards (new and renewals) from FY2014 to FY2025 under this notice and the notices it replaced: $2,110,157 in first-year total cost, median $754,666.

Most frequent study sections

  1. Special Emphasis Panel[ZDA1 GXM-A (03)]3

Most frequent institutions

  1. MEHARRY MEDICAL COLLEGE1
  2. RUSH UNIVERSITY MEDICAL CENTER1
  3. STATE UNIVERSITY NEW YORK STONY BROOK1
Competing awards under RFA-DA-22-003 and the notices it replaced
FYProjectPIsInstitutionFirst-year costStudy section
2022cART, neuroHIV, cocaine abuse and the mPFC neuron/astrocyte dysfunction1R01DA057197-01HU, XIU-TIRUSH UNIVERSITY MEDICAL CENTER, IL$786,328ZDA1
2022Role of GRIN2 in ART and SUD associated neurological deficits.1R01DA057204-01DASH, CHANDRAVANUMEHARRY MEDICAL COLLEGE, TN$754,666ZDA1
2022Cellular and circuitry mechanisms of NRTI-induced pain pathogenesis in the context of opioids and HIV1R01DA057195-01TANG, SHAO-JUNSTATE UNIVERSITY NEW YORK STONY BROOK, NY$569,163ZDA1

Data: Grants.gov's daily extract and NIH's notice pages and award files, in ScienceGraph release conductgrants-2026-11-09-0.1.0. An award is listed only where NIH's own record names the notice, and a PI only by NIH's profile ID. Grants.gov and NIH do not endorse ScienceDex.

ScienceDex for faculty

Your academic CV and NIH biosketch

Make your CV in your school's format and your NIH biosketch from it, then download both as Word files.